Scilex Pharmaceuticals, Inc.
Nasdaq SCLX · Palo Alto, CA
Works in Cardiovascular · Neurology
Scilex Pharmaceuticals, Inc. is a clinical trial sponsor based in Palo Alto, CA, listed as Nasdaq SCLX. It has no active clinical trials as lead sponsor; its trials since 2021 were in Cardiovascular and Neurology. Since 2021 it has completed 10 trials and stopped 0 early. Its FDA record on file shows 1 inspection.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · Nasdaq SCLX
Fundraising
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
On the market
3 approved drug applications with a product on the market.
Questions about Scilex Pharmaceuticals, Inc
No warning letter naming Scilex Pharmaceuticals, Inc is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Scilex Pharmaceuticals, Inc. The latest inspection ended on 2026-05-20 and was classified VAI (voluntary action indicated). FDA posts a classification after its review, often months after the inspection ended.
Scilex Pharmaceuticals, Inc has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 10 trials and stopped 0 early.
Scilex Pharmaceuticals, Inc is based in Palo Alto, CA and is listed as Nasdaq SCLX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Scilex Pharmaceuticals, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-06.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Scilex Pharmaceuticals, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.